Madrigal Pharmaceuticals, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Madrigal Pharmaceuticals, Inc. Website Screenshot

http://www.madrigalpharma.com

Madrigal Pharmaceuticals, Inc. Company Intro

Madrigal Pharmaceuticals, Inc. (Nasdaq: MGDL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.

Industry

Healthcare

Madrigal Pharmaceuticals, Inc. Headquaters

Four Tower Bridge
West Conshohocken,19428
United States


Madrigal Pharmaceuticals, Inc. Share price

21 Oct 2020 02:02 GMT

$128.81

1.13 (0.89 %)


Madrigal Pharmaceuticals, Inc. Market cap

$1.95 B


WMC RANKING

2020

Madrigal Pharmaceuticals, Inc. # 481

Biotechnology



Latest Madrigal Pharmaceuticals, Inc. News

News 20 Oct 2020

Heterozygous Familial Hypercholesterolemia Drug Market ...

... like Daewoong Co Ltd, Madrigal Pharmaceuticals Inc, Esperion Therapeutics Inc and Gemphire Therapeutics Inc. The report profiles various product offerings ...

News 20 Oct 2020

Raymond James Sticks to Its Buy Rating for NGM ...

The company's shares closed last Monday at $16.28. ... Seedhouse covers the Healthcare sector, focusing on stocks such as Madrigal Pharmaceuticals, Alexion ...

News 20 Oct 2020

Hypopharyngeal Cancer Treatment Market Demand & Future ...

Celldex Therapeutics Inc; Merck & Co Inc; Incyte Corp; Madrigal Pharmaceuticals Inc. Manufacturing facilities, company overview, and competition backdrop are ...

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Madrigal Pharmaceuticals, Inc. 0 0 0 0 0 0 0
Alexion Pharmaceuticals, Inc. 100 13.16 100 19 0 0 99.11
Vertex Pharmaceuticals Incorporated 97.58 100 3.65 30 0 0 100
3SBio Inc. 96.05 0 0 4 0 0 3.03
Incyte Corporation 40.27 14.26 7.06 100 0 0 91.10

Madrigal Pharmaceuticals, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Madrigal Pharmaceuticals, Inc. $0 $94,972 $-83,948 $1.95B 481
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $27.177B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $57.436B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥19.572B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.532B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Madrigal Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors



Madrigal Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors